Incorporating New Exposure Model In Drinking Water Calculations
Katherine Pelch, PhD April 24, 2019 CHE-Alaska
Incorporating New Exposure Model In Drinking Water Calculations - - PowerPoint PPT Presentation
Incorporating New Exposure Model In Drinking Water Calculations Katherine Pelch, PhD April 24, 2019 CHE-Alaska Calculating MCLs 1 2 3 Target Human Serum Level Dosimetric Adjustment Factor Animal serum level Volume of distribution
Katherine Pelch, PhD April 24, 2019 CHE-Alaska
@endo_exchange
2
Target Human Serum Level Animal serum level
÷
Uncertainty factors Dosimetric Adjustment Factor Volume of distribution X Ln(2) / human half-life Reference Dose Exposure Estimates Relative source contribution ÷ Ingestion rate Maximum Contaminant Level (MCL) 1 2 3 4 5
@endo_exchange
3
RSC
chemical that is attributed to or allocated to tap water
Relative source contribution (RSC) Ingestion rate
*Methodology for Deriving Ambient Water Quality Criteria for the Protection of Human Health (2000) https://www.epa.gov/sites/production/files/2018-10/documents/methodology-wqc-protection-hh-2000.pdf
NJ NH PFOA 0.2 0.4 PFOS 0.2 0.5 PFHxS na 0.5 PFNA 0.5 0.5
Example RSCs Used
@endo_exchange
4
Ingestion Rates Used Ingestion Rate
body weight basis
different life stages*
per body weight basis than adults
*U.S. EPA. Exposure Factors Handbook 2011 Edition (Final Report) https://cfpub.epa.gov/ncea/risk/recordisplay.cfm?deid=236252
L/kg/day Based on: NJ 0.029 non-pregnant, non-lactating adult NH 0.055 lactating woman VT 0.175 first year of life based on combined direct and indirect water intake
Relative source contribution (RSC) Ingestion rate
@endo_exchange
5
1. Many PFAS are bioaccumlative 2. PFAS cross the placenta 3. PFAS are transferred to infants in breastmilk 4. Infants are particularly vulnerable
weight basis
@endo_exchange
6
MDH PFOA HBGV MDH PFOS HBGV MDH PFHxS HBGV
@endo_exchange
7
with existing body burden
contaminated water throughout life
@endo_exchange
8
10 20 30 40 50 60 70 10 20 30 40 50 Serum Concentration (µg/L) Age (years)
INPUT OUTPUT
50% of the reference serum concentration 20% of the reference serum concentration
Dependent on target human serum level
@endo_exchange
9
10 20 30 40 50 60 70 80 90 100 10 20 30 40 50 Serum Concentration (µg/L) Age (years)
50% of reference serum concentration 20% of reference serum concentration
0.050 µg/L (50 ppt) 0.040 µg/L (40 ppt) 0.035 µg/L (35 ppt)
@endo_exchange
10
Breastfed Infant Scenario PFOA Serum Concentration at Water Concentration 0.035 µg/L
10 20 30 40 50 60 70 10 20 30 40 50 Serum Concentration (µg/L) Age (years) 50% of reference serum conc. 20% of reference serum conc. 10 20 30 40 50 60 70 10 20 30 40 50 Serum Concentration (µg/L) Age (years)
Formula-fed Infant Scenario PFOA Serum Concentration at Water Concentration 0.150 µg/L
50% of reference serum conc. 20% of reference serum conc.
The drinking water level suggested for formula-fed infants (150 ppt), would not have been protective for breastfed infants, so MDH set a health based guidance value of 35 ppt based
@endo_exchange
11
Impacts of Exposure Assumptions in NHDES MCL Calculations
Modeled Serum PFOA Concentrations Modeled Serum PFOS Concentrations
10 20 30 40 50 60 70 80 90 10 20 30 40 50 Serum Concentration (µg/L) Age (years)
50% 20%
38 ppt (NHDES proposed MCL) 10 ppt (using model for breastfed infants)
10 20 30 40 50 60 70 10 20 30 40 50 Serum Concentration (µg/L) Age (years)
50% 20%
70 ppt (NHDES proposed MCL) 38 ppt (using model for breastfed infants)
>50% for 8.5 years >50% for 9 years
@endo_exchange
12 5 10 15 20 25 30 10 20 30 40 50 Serum Concentration (µg/L) Age (years)
50% 20%
23 ppt (NHDES proposed MCL) 7 ppt (using model for breastfed infants)
Impacts of Exposure Assumptions in NHDES MCL Calculations
10 20 30 40 50 60 70 80 10 20 30 40 50 Serum Concentration (µg/L) Age (years)
85 ppt (NHDES proposed MCL) 49 ppt (using model for breastfed infants)
50% 20%
>50% for 11.5 years
Modeled Serum PFNA Concentrations Modeled Serum PFHxS Concentrations
>50% for 9.5 years
@endo_exchange
13
@endo_exchange
14
Carol Kwiatkowski Executive Director Kim Schultz Oil & Gas Program Coordinator Christina Ribbens Business Manager
Funding
https://endocrinedisruption.org/assets/media/documents/TEDX_NHDES_comments.pdf View our full comments to NHDES at: